#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hairy cell leukaemia recurrent Stevens-Johnson syndrome Synovial sarcoma metastatic Osteosarcoma Non-small cell lung cancer recurrent Biliary cancer metastatic Autoimmune demyelinating disease Langerhans' cell histiocytosis Wiskott-Aldrich syndrome Chordoma Malignant oligodendroglioma Tourette's disorder Netherton's syndrome Nephropathy Acute leukaemia More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Noonan syndrome – Diagnostics Cystic fibrosis – Treatment Methylmalonic acidaemia – Diagnostics Haemophagocytic lymphohistiocytosis – Trials in Disease Hereditary neuropathic amyloidosis – Trials in Disease X-linked lymphoproliferative syndrome – Life with Disease Lysosomal storage disorder Progressive supranuclear palsy – Treatment Chronic granulomatous disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ezetimibe Rly-4008 Cyclophosphamide Monohydrate Riociguat Panobinostat Alxn1850 Immunglobulin Vortioxetine Hydrobromide Pc14586 Fluorouracil [99MTC]PSMA I&S C1 Esterase Inhibitor (Human) Gns561 Iodine (123I) Iobenguane O15-Water Microcrystalline Cellulose Ttf-Ngr Glimepiride Tas3351 Carfilzomib More therapies…

    Learn about Your Condition

    Metastases to biliary tract Bronchiolitis Overweight Prostatitis Escherichia coli Asplenia Diabetic retinopathy Acute respiratory failure Retroperitoneal fibrosis Cutaneous T-cell lymphoma Obstructive pancreatitis Desmoid tumour Neuropathy peripheral Cervix carcinoma stage III Glomerulonephritis chronic Metastasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study of Bevacizumab for Adults with Long-Lasting Breathing Problems After COVID-19 Infection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Bevacizumab
    France

  • Testing the Safety of Combining Tocilizumab with Other Biologic Drugs in Patients with Rheumatoid Arthritis or Psoriatic Arthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tocilizumab
    Spain

  • A Study of Fentanyl Nasal Spray Safety and Effectiveness for Pain Management in Patients Requiring Pain Relief

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Fentanyl
    • Fentanyl Citrate
    Hungary

  • Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • ACICLOVIR SODIUM
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    Sweden

  • Comparing certolizumab pegol and belimumab for patients with moderate or severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Certolizumab Pegol
    • Belimumab
    Poland

  • Study of Zirconium-89 Girentuximab as a Diagnostic Tool for Patients with Von-Hippel Lindau Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Von Hippel-Lindau disease
    Investigated Drugs:
    • ZIRCONIUM (89ZR) GIRENTUXIMAB
    Italy
Previous Page
1 … 777 778 779 780 781 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!